Rising Star: Winston & Strawn's Kurt Mathas
Law360 (August 16, 2018, 2:54 PM EDT) -- Winston & Strawn LLP partner Kurt Mathas helped Teva get a generic version of the testosterone replacement therapy drug Axiron on the market by getting the Federal Circuit to invalidate a...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login